{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of Stellate Ganglion Block to Treat Anosmia and Dysgeusia Associated With COVID-19: A Narrative Review

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define and explain the pathology of anosmia and ageusia.
  2. Describe the anatomy of the stellate ganglion and the history of stellate ganglion block.
  3. Explain why stellate ganglion block is effective in management of anosmia and ageusia.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of current research regarding the use of stellate ganglion block to treat anosmia and dysgeusia associated with COVID-19 by achieving a minimum score of 70% on the outcomes-based posttest
Price: $49.00

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: TPM1023
Published: Oct 2023
Expires: 9/5/2025
Required Passing Score: 7/10 (70%)
Authors: Christopher P. Cheng, AB; Suhas K. Etigunta, BS; Alopi M. Patel, MD; Paul Shekane, MD